{"Symbol": "HOLX", "AssetType": "Common Stock", "Name": "Hologic Inc", "Description": "Hologic, Inc. is a medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.", "CIK": "859737", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS", "Address": "250 CAMPUS DRIVE, MARLBOROUGH, MA, US", "OfficialSite": "https://www.hologic.com", "FiscalYearEnd": "September", "LatestQuarter": "2024-12-31", "MarketCapitalization": "13134821000", "EBITDA": "1279100000", "PERatio": "18.41", "PEGRatio": "1.243", "BookValue": "21.16", "DividendPerShare": "None", "DividendYield": "None", "EPS": "3.16", "RevenuePerShareTTM": "17.29", "ProfitMargin": "0.184", "OperatingMarginTTM": "0.229", "ReturnOnAssetsTTM": "0.071", "ReturnOnEquityTTM": "0.158", "RevenueTTM": "4039000000", "GrossProfitTTM": "2461000000", "DilutedEPSTTM": "3.16", "QuarterlyEarningsGrowthYOY": "-0.155", "QuarterlyRevenueGrowthYOY": "0.009", "AnalystTargetPrice": "75.4", "AnalystRatingStrongBuy": "4", "AnalystRatingBuy": "3", "AnalystRatingHold": "14", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "18.41", "ForwardPE": "13.42", "PriceToSalesRatioTTM": "3.252", "PriceToBookRatio": "2.677", "EVToRevenue": "3.304", "EVToEBITDA": "9.94", "Beta": "0.828", "52WeekHigh": "84.67", "52WeekLow": "55.89", "50DayMovingAverage": "61.71", "200DayMovingAverage": "73.79", "SharesOutstanding": "225723000", "DividendDate": "None", "ExDividendDate": "None"}